PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Researchgrid.416197.c, Yaba, Lagos, Nigeria.\', \'Institute for Global Health, University College Londongrid.83440.3b, London, United Kingdom.\', \'Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.\', \'Clinical Diagnostic Laboratory, Nigerian Institute of Medical Researchgrid.416197.c, Yaba, Lagos, Nigeria.\', \'Nigerian Institute of Medical Researchgrid.416197.c, Yaba, Lagos, Nigeria.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/Spectrum.00680-21
?:doi
?:hasPublicationType
?:journal
  • Microbiology spectrum
is ?:pmid of
?:pmid
?:pmid
  • 34612691
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.814
?:rankingScore_hIndex
  • 21
?:title
  • Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all